Français
ItalianoBond Novartis AG 3.8% ( US66989HAT59 ) in USD
| Issuer | Novartis AG | ||||||||
| Market price |  99.50 % ⇌ |
||||||||
| Country |  Switzerland
|
||||||||
| ISIN code |
 US66989HAT59 ( in USD )
|
||||||||
| Interest rate | 3.8% per year ( payment 2 times a year) | ||||||||
| Maturity | 18/09/2029 | ||||||||
|
Prospectus brochure in PDF format |
|||||||||
| Minimal amount | / | ||||||||
| Total amount | / | ||||||||
| Cusip | 66989HAT5 | ||||||||
| Standard & Poor's ( S&P ) rating | AA- ( High grade - Investment-grade ) | ||||||||
| Moody's rating | Aa3 ( High grade - Investment-grade ) | ||||||||
| Next Coupon | 18/09/2026 ( In 22 days ) | ||||||||
| Detailed description |
Novartis AG is a Swiss multinational pharmaceutical company that researches, develops, manufactures, and markets a broad range of innovative medicines and healthcare solutions globally. The Bond issued by Novartis AG ( Switzerland ) , in USD, with the ISIN code US66989HAT59, pays a coupon of 3.8% per year. The coupons are paid 2 times per year and the Bond maturity is 18/09/2029 The Bond issued by Novartis AG ( Switzerland ) , in USD, with the ISIN code US66989HAT59, was rated Aa3 ( High grade - Investment-grade ) by Moody's credit rating agency. The Bond issued by Novartis AG ( Switzerland ) , in USD, with the ISIN code US66989HAT59, was rated AA- ( High grade - Investment-grade ) by Standard & Poor's ( S&P ) credit rating agency. |
||||||||
| |||||||||